Meta-Analyses of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy | Zendy

Robert A. Leonardi | Zendy; E. Kransdorf | Zendy; David L. Simel | Zendy; Andrew Wang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Meta-Analyses of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy

Author(s) -

Robert A. Leonardi,

E. Kransdorf,

David L. Simel,

Andrew Wang

Publication year - 2010

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.109.916676

Subject(s) - medicine , septal myectomy , alcohol septal ablation , hypertrophic cardiomyopathy , cardiology , odds ratio , surgery , cardiomyopathy , muscle hypertrophy , sudden cardiac death , heart failure , obstructive cardiomyopathy

Septal reduction for obstructive hypertrophic cardiomyopathy may be performed by surgical myectomy or alcohol septal ablation (ASA). Unlike surgical myectomy, ASA creates an intramyocardial scar that may potentiate the risk of ventricular arrhythmias and sudden cardiac death (SCD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research